For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

A letter to the US public on the AMA website, signed by 75+ medical societies, stresses the vital importance of influenza, RSV, and COVID-19 vaccines.

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

by at least 11% and up to 18%. The CDC advises adults 65 and older to receive the enhanced vaccines, as many already do. More good news: Vaccines to prevent respiratory syncytial virus in people 60 ...

Moderna has been banking on revenue from newer mRNA shots to make up for declining sales of its COVID vaccine and weaker-than-expected uptake of its respiratory syncytial virus vaccine ... which ...

The Health and Human Services Department under Kennedy took unprecedented steps to change how vaccines are evaluated, ...

Deana Hendrickson, 66, who provides daily care for three young grandsons in Los Angeles, sought an additional MMR shot, ...

The Department of Health and Human Services under Robert F. Kennedy Jr. has taken unprecedented steps to change how vaccines ...

Studies have found important benefits from the new RSV immunization and enhanced versions of the flu shot. Plus, the shingles ...

A federal vaccine advisory committee plans to review the childhood vaccination schedule and scrutinize vaccines that have ...

Zgura recently received a flu shot and RSV vaccine. Over the last few months, the FDA approved the first RSV vaccine for infants and adults 60 and over. “For the kids who are younger, under 6 months ...

As Health Secretary Robert F. Kennedy Jr. continues to overhaul the CDC and FDA, here are the vaccine schedules that experts ...